DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+2.41%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$198M
AUM Growth
+$198M
(+2%)
Cap. Flow
+$7.4M
Cap. Flow
% of AUM
3.74%
Top 10 Holdings %
Top 10 Hldgs %
42.17%
Holding
97
New
13
Increased
28
Reduced
18
Closed
14
Top Buys
| 1 |
Lifecore Biomedical
LFCR
|
$1.87M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$1.52M |
| 3 |
Advanced Micro Devices
AMD
|
$1.45M |
| 4 |
NewAmsterdam Pharma
NAMS
|
$1.42M |
| 5 |
Baidu
BIDU
|
$1.03M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
$4.96M |
| 2 |
Alibaba
BABA
|
$4.59M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$2.33M |
| 4 |
Turning Point Brands
TPB
|
$2.3M |
| 5 |
B
Barrick Mining Corporation
B
|
$1.39M |
Sector Composition
| 1 | Healthcare | 36.9% |
| 2 | Technology | 19.76% |
| 3 | Communication Services | 8.6% |
| 4 | Consumer Discretionary | 5.34% |
| 5 | Financials | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Micron Technology
MU
$133B
| $15.4M | 7.47% | 183,500 +7,000 | +4% | +$589K |
|
2
argenx
ARGX
$43.6B
| $12.3M | 5.95% | 20,000 | – | – |
|
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $10.9M | 5.29% | 57,400 -12,250 | -18% | -$2.33M |
|
|
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.33M | 4.03% | 99,757 -750 | -0.7% | -$62.6K |
|
5
Amazon
AMZN
$2.44T
| $6.58M | 3.18% | 30,000 -4,500 | -13% | -$987K |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.34M | 3.07% | 8,900 +1,150 | +15% | +$819K |
|
7
Oracle
ORCL
$635B
| $6.08M | 2.94% | 36,500 +1,500 | +4% | +$250K |
|
|
8
Advanced Micro Devices
AMD
$264B
| $6.04M | 2.92% | 50,000 +12,000 | +32% | +$1.45M |
|
9
AbbVie
ABBV
$372B
| $5.6M | 2.71% | 31,500 +500 | +2% | +$88.9K |
|
10
Eli Lilly
LLY
$657B
| $5.4M | 2.61% | 7,000 | – | – |
|
11
Bank of America
BAC
$376B
| $5.25M | 2.54% | 119,500 | – | – |
|
12
iShares Gold Trust
IAU
$50.6B
| $4.95M | 2.4% | 100,000 | – | – |
|
13
Xencor
XNCR
$580M
| $4.67M | 2.26% | 203,167 -6,312 | -3% | -$145K |
|
14
SPDR Gold Trust
GLD
$107B
| $4.36M | 2.11% | 18,000 | – | – |
|
|
15
Baidu
BIDU
$32.8B
| $4.03M | 1.95% | 47,750 +12,250 | +35% | +$1.03M |
|
|
16
Lifecore Biomedical
LFCR
$285M
| $4.01M | 1.94% | 539,989 +251,511 | +87% | +$1.87M |
|
17
iShares Silver Trust
SLV
$19.6B
| $3.82M | 1.85% | 145,000 -4,500 | -3% | -$118K |
|
18
Incyte
INCY
$16.5B
| $3.35M | 1.62% | 48,500 +250 | +0.5% | +$17.3K |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $3.25M | 1.57% | 147,500 +34,500 | +31% | +$760K |
|
20
Citigroup
C
$178B
| $3.17M | 1.53% | 45,000 +7,500 | +20% | +$528K |
|
|
21
Ionis Pharmaceuticals
IONS
$6.79B
| $2.9M | 1.4% | 82,882 +43,382 | +110% | +$1.52M |
|
22
VanEck Gold Miners ETF
GDX
$19B
| $2.8M | 1.35% | 82,500 +7,500 | +10% | +$254K |
|
23
Zimmer Biomet
ZBH
$21B
| $2.41M | 1.17% | 22,819 -500 | -2% | -$52.8K |
|
24
iShares Russell 2000 ETF
IWM
$67B
| $2.38M | 1.15% | 10,750 | – | – |
|
|
25
NewAmsterdam Pharma
NAMS
$2.71B
| $2.3M | 1.11% | 89,400 +55,400 | +163% | +$1.42M |
|